Cellsonics
ACQUIRED (1).png
Enzyme-free, easily obtainable single cells & nucleic acids from solid tissue
INVESTMENt

June, 2019

Sector

Science

FUND

Fund I

location

Northern California

co-investors

Vertical Venture Partners

Image-empty-state_edited.jpg

Steve Levers

Co-Founder & CEO

Quintuple aim
Alertive.png

Cellsonics is revolutionizing single-cell sample preparation, delivering the individual characteristics of each sample for a precision medicine approach to the analysis, treatment, and diagnosis of disease. The company has developed tools to process single cells and nucleic acids from the solid tissue without compromising the gene expression data.